npc (Hamilton Company)
Structured Review
Npc, supplied by Hamilton Company, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/npc/product/Hamilton Company
Average 86 stars, based on 1 article reviews
Price from $9.99 to $1999.99
Images
1) Product Images from "Small extracellular vesicles derived from human induced pluripotent stem cell-differentiated neural progenitor cells mitigate retinal ganglion cell degeneration in a mouse model of optic nerve injury"
Article Title: Small extracellular vesicles derived from human induced pluripotent stem cell-differentiated neural progenitor cells mitigate retinal ganglion cell degeneration in a mouse model of optic nerve injury
Journal: Neural Regeneration Research
doi: 10.4103/NRR.NRR-D-23-01414
Figure Legend Snippet: Isolation and characterization of sEVs from hiPSCs and hiPSC-NPCs. (A) Schematic illustration of direct NPC differentiation of hiPSCs. (B, C) Representative morphology and immunostaining of hiPSCs and hiPSC-NPCs. hiPSCs showed a typical clone morphology with SOX2 and TRA-1-60 expression. hiPSC-NPCs showed a typical epithelium morphology with PAX6 and NESTIN expression. Scale bars: 100 μm. (D) Schematic of sEV isolation protocol. (E) Representative TEM images of NPC-sEVs showed a typical cup-like structure. Scale bar: 200 nm. (F) Size distribution of NPC-sEVs. The inset is a snapshot image of video tracking. (G) Western blot results for positive (SDCBP, TSG101, and ALIX) and negative (calnexin) biomarkers of NPC-sEVs and parental cells. ALIX: Apoptosis-linked gene 2-interacting protein X; hiPSC: human induced pluripotent stem cell; NEM: neural expansion medium; NIM: neural induction medium; NPC: neuronal progenitor cell; PAX6: paired box 6; SDCBP: syndecan binding protein; sEV: small extracellular vesicle; SOX2: SRY-box transcription factor 2; TRA-1-60: tumor-related antigen-1-60; TSG101: tumor susceptibility 101.
Techniques Used: Isolation, Immunostaining, Expressing, Western Blot, Binding Assay
Figure Legend Snippet: Neuroprotective effects of sEVs from hiPSCs and hiPSC-NPCs by OCT and HE staining. (A) Schematic of animal experiments. (B) Representative OCT images of mice at 7 and 14 days post-ONC. Thickness of the retina decreased with time. Scale bar: 200 μm. (C) OCT statistical results of mean thickness of the GCC layer ( n = 16). * P < 0.05, ** P < 0.01, hiPSC-sEVs group vs . PBS group; # P < 0.05, ## P < 0.01, NPC-sEVs group vs . PBS group. (D) Representative image of the GCC layer from mice at 7 and 14 days post-ONC. Similar to the results obtained by OCT, thickness of the retina decreased with time. Scale bars: 20 μm. (E) Statistical results of mean thickness of the GCC layer ( n = 12). (F) Quantification of mean number of cells in the GCL ( n = 12). * P < 0.05, *** P < 0.001. Data are expressed as mean ± SEM (C) or mean ± SD (E and F), and were analyzed by Student’s t -test (C) or one-way analysis of variance followed by Tukey’s post hoc test (E and F). GCC: Ganglion cell complex; GCL: ganglion cell layer; HE: hematoxylin-eosin; hiPSC: human induced pluripotent stem cell; IF: immunofluorescence; iPSC: induced pluripotent stem cell; NPC: neural progenitor cell; ns: not significant; OCT: optical coherence tomography; ONC: optic nerve crush; ONH: optic nerve head; PBS: phosphate buffer saline; sEV: small extracellular vesicle; VEP: visual evoked potential.
Techniques Used: Staining, Immunofluorescence, Tomography, Saline
Figure Legend Snippet: RGC survival of ONC mice with or without sEV treatment. (A) Flat-mounted retinas of ONC mice with or without treatment with sEVs on day 7 and day 14 post-ONC. RGC degeneration was progressive after ONC. (B) Schematic diagram of different regions of flat-mounted retinas (central, paracentral, and peripheral). Created with Microsoft PowerPoint Professional 2019. (C) Representative image of central, paracentral, and peripheral retinal regions in ONC model mice with or without treatment with sEVs. Following treatment with hiPSC-sEVs, more RGCs survived in retinas on day 7 post-ONC. However, following treatment with NPC-sEVs, more RGCs survived in retinas on both days 7 and 14. Scale bars: 100 μm. (D) Quantification of mean number of RGCs in different retinal regions at 7 and 14 days ( n = 8/group). Data are expressed as mean ± SD. * P < 0.05, ** P < 0.01, *** P < 0.001 (one-way analysis of variance followed by Tukey’s post hoc test). hiPSC: Human induced pluripotent stem cell; iPSC: induced pluripotent stem cell; NPC: neural progenitor cell; ns: not significant; ONC: optic nerve crush; PBS: phosphate buffer saline; RGC: retinal ganglion cell; sEV: small extracellular vesicle.
Techniques Used: Saline
Figure Legend Snippet: Anti-inflammatory effects of sEVs from hiPSCs and hiPSC-NPCs. (A) Frozen sections of retinas on days 7 and 14. Migrated microglia were reduced in sEV-treated retinas on day 7 but not on day 14 after ONC. Scale bar: 50 μm. (B) Quantification of mean number of IBA1-positive cells per field ( n = 5). (C) Flat-mounted retinas of ONC CX3CR1-GFP mice on day 7. The number of microglia increased in the retina after ONC, but decreased in sEV-treated retinas. (D) Representative images of central, paracentral, and peripheral retinal regions in the ONC model of CX3CR1-GFP mice with or without treatment with sEVs on day 7. The number of microglia and grid-crossed points per microglia were reduced in sEV-treated retinas on day 7. Scale bar: 100 μm. (E) Statistical results of mean number of microglia (CX3CR1-GFP positive cells) per field of different retinal regions ( n = 5). (F) Quantification of mean grid-crossed points per microglia ( n = 5). Data are expressed as mean ± SD. * P < 0.05, ** P < 0.01, *** P < 0.001 (one-way analysis of variance followed by Tukey’s post hoc test). CX3CR1: CX3C chemokine receptor 1; DAPI: 4’,6-diamidino-2-phenylindole; GFP: green fluorescent protein; Iba1: ionized calcium-binding adapter molecule 1; hiPSC: human induced pluripotent stem cell; iPSC: induced pluripotent stem cell; NPC: neural progenitor cell; ns: not significant; ONC: optic nerve crush; PBS: phosphate buffer saline; sEVs: small extracellular vesicles.
Techniques Used: Binding Assay, Saline
Figure Legend Snippet: Protective effect of NPC-sEVs on visual function in ONC mice. (A) Schematic diagram of FVEP. Created with Microsoft PowerPoint Professional 2019. (B) Mean amplitude of N1–P1 waves detected by FVEP on day 7 ( n = 8). Data are expressed as mean ± SD. *** P < 0.001 (one-way analysis of variance followed by Tukey’s post hoc test). (C) Overlapping FVEP waves in ONC mice with or without treatment with NPC-sEVs on day 7. FVEP: Flash visual evoked potentials; NPC: neural progenitor cell; ONC: optic nerve crush; PBS: phosphate buffer saline; sEV: small extracellular vesicle.
Techniques Used: Saline
Figure Legend Snippet: miRNA sequencing analysis of sEVs derived from hiPSCs and NPCs. (A) Volcano plot of differentially expressed miRNAs from hiPSC-sEVs and NPC-sEVs. (B, C) KEGG and GO pathway enrichment analyses of differentially expressed miRNAs. (D) Heatmap of differentially expressed miRNAs related to neural pathways. (E) Expression rank of miRNAs in NPC-sEVs. (F) Pie chart showing the percentage of 17 neuroprotective miRNAs in the top 50 miRNAs in term of expression. DEG: Differentially expressed gene; GO: Gene Ontology; hiPSC: human induced pluripotent stem cell; KEGG: Kyoto Encyclopedia of Genes and Genomes; miRNA: microRNA; NPC: neural progenitor cell; sEV: small extracellular vesicle; TPM: tag per million.
Techniques Used: Sequencing, Derivative Assay, Expressing